VYNE Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. VYNE Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 11% to $424,000. The net income raised on -$28,452,000 and profit margin reached -6710%. Total operating expenses were $29,682,000.
Profit Margin
| 2015 | 0 | -4.60M | |
|---|---|---|---|
| 2016 | 674K | -14.06M | -2087.24% |
| 2017 | 4.58M | -29.07M | -634.57% |
| 2018 | 10.64M | -51.44M | -483.51% |
| 2019 | 443K | -70.46M | -15906.09% |
| 2020 | 20.99M | -255.56M | -1217.4% |
| 2021 | 14.75M | -73.32M | -496.98% |
| 2022 | 477K | -33.94M | -7116.35% |
| 2023 | 424K | -28.45M | -6710.38% |
VYNE Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 424K | 477K | 14.75M | 20.99M | 443K | 10.64M | 4.58M | 674K | 0 |
Cost of revenue | 0 | 0 | 3.34M | 1.39M | 350K | 0 | 0 | 0 | 0 |
Gross profit | 424K | 477K | 11.40M | 19.60M | 93K | 10.64M | 4.58M | 674K | 0 |
Operating exp. | |||||||||
Research and development | 16.30M | 18.38M | 24.95M | 43.53M | 53.76M | 52.98M | 29.00M | 11.25M | 2.92M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 29.68M | 34.77M | 79.43M | 133.07M | 76.24M | 65.17M | 34.17M | 15.00M | 4.60M |
Operating income | -29.25M | -34.29M | -68.03M | -113.47M | -76.24M | -54.53M | -29.59M | -14.33M | -4.60M |
Other income (expenses), net | 1.38M | 363K | -5.74M | -142.35M | 2.53M | 3.09M | 517K | 264K | 0 |
Income before tax | -27.87M | -33.93M | -73.77M | -255.82M | -73.70M | -51.44M | -29.07M | -14.06M | -4.60M |
Income tax expense | 0 | 13K | -448K | -258K | -3.23M | 3.09M | -8K | 0 | 0 |
Net income | -28.45M | -33.94M | -73.32M | -255.56M | -70.46M | -51.44M | -29.07M | -14.06M | -4.60M |
Earnings per share | |||||||||
Basic EPS | -2.77 | -10.65 | -25.65 | -141.9 | -149.48 | -170.94 | -101.65 | -87.78 | -28.75 |
Diluted EPS | -2.77 | -10.65 | -25.65 | -141.9 | -149.48 | -170.94 | -101.65 | -87.78 | -28.75 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |